This announcement is a separate document:
CARIMIN: Change in Nomination and Remuneration Committee - ENCIK WAN MUHAMAD HATTA BIN WAN MOS
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
15:46
Hengrui Pharmaceutical: The subsidiary received an approval notice for clinical trials of the HRS-3802 extended-release tablet drug
Jiangsu Hengrui Pharmaceuticals-2.53%
15:44
The China Academy of Information and Communications Technology has released the "AI Development Report (2024)".
15:40
Sinopec's sales in November amounted to 1.77 billion New Taiwan dollars.